Data / Research funding / Arizona / Translational Genomics Research Inst
Translational Genomics Research Inst: 20 NIH awards ($45.3M), fiscal years 2021 to 2026
Translational Genomics Research Inst in Phoenix, AZ is funded under 20 NIH awards ($45.3M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- J19ZXYATJLT3
- State
- Arizona
Awards
20 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Processing and Analyzing Mass Spectrometry Proteomics Data for the Longevity Consortium | NIH | National Institute on Aging | 2024 to 2025 | $17,478,926 | September 30, 2004 | August 31, 2029 | SCHORK, NICHOLAS JOSEPH | reporter.nih.gov |
| Spatiotemporal genomic regulation of disease initiation and progression in pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,775,343 | January 1, 2019 | April 30, 2028 | BANOVICH, NICHOLAS ELI | reporter.nih.gov |
| Integrative Cross Species Analysis for Longevity Drug Target Identification | NIH | National Institute on Aging | 2021 to 2024 | $3,259,121 | September 15, 2019 | August 31, 2025 | SCHORK, NICHOLAS JOSEPH | reporter.nih.gov |
| Extracellular vesicle cargo and risk of NAFLD and NASH in U.S. youth | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,153,279 | April 15, 2022 | February 28, 2027 | DISTEFANO, JOHANNA K | reporter.nih.gov |
| Integrated analysis of multi-omic QTLs at single cell resolution | NIH | National Human Genome Research Institute | 2022 to 2025 | $2,938,710 | September 15, 2022 | June 30, 2026 | BANOVICH, NICHOLAS ELI | reporter.nih.gov |
| MYCOBACTERIUM TUBERCULOSIS PROTEOME-WIDE EPITOPE DISCOVERY AND HOST TRANSCRIPTOME-WIDE T CELL PHENOTYPING IN HIGH DISEASE BURDEN POPULATIONS | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,545,675 | September 30, 2025 | September 29, 2026 | ALTIN, JOHN | reporter.nih.gov |
| High-resolution, virome-wide infection analysis in type 1 diabetes birth cohorts | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,459,418 | June 1, 2024 | May 31, 2027 | ALTIN, JOHN | reporter.nih.gov |
| A scalable platform for highly-multiplexed analysis of antibody reactivity from <1uL of blood | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,420,790 | April 10, 2020 | March 31, 2025 | ALTIN, JOHN | reporter.nih.gov |
| A Large-scale Extracellular Vesicle RNA-seq Resource for Parkinsons Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,250,030 | June 1, 2023 | May 31, 2025 | CRAIG, DAVID W | reporter.nih.gov |
| Profiling extracellular vesicle cargo in obesity and type 2 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $2,227,924 | September 20, 2019 | July 31, 2025 | DISTEFANO, JOHANNA K | reporter.nih.gov |
| Genetic and Epigenetic Strategies for the Acquisition of Telomere Maintenance in Human Cancer Cells | NIH | National Cancer Institute | 2021 to 2023 | $737,037 | April 1, 2018 | July 31, 2024 | BARTHEL, FLORIS | reporter.nih.gov |
| Proteome-wide Discovery of Diagnostic Targets for Coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $523,993 | December 1, 2023 | October 31, 2025 | MEAD, HEATHER LYNN | reporter.nih.gov |
| Understanding the natural Coccidioides bioaerosol in time and space and its relationship to disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $287,269 | March 16, 2020 | February 28, 2023 | ENGELTHALER, DAVID M | reporter.nih.gov |
| A novel approach for deep phenotyping the CD4 T cell response to Mycobacterium Tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $280,275 | February 18, 2020 | July 31, 2022 | ALTIN, JOHN | reporter.nih.gov |
| Targeting cellular senescense in pancreatic cancer | NIH | National Cancer Institute | 2025 | $269,280 | February 1, 2025 | January 31, 2027 | HAN, HAIYONG | reporter.nih.gov |
| Characterizing the effects of cis-regulatory variation on patient outcomes and treatment response in Multiple Myeloma | NIH | National Cancer Institute | 2021 to 2023 | $214,940 | January 1, 2021 | September 22, 2023 | BUI-RABORN, LINH T | reporter.nih.gov |
| Identification of novel blood-based biomarkers of Alzheimer's Disease by pseudotime analysis | NIH | National Institute on Aging | 2022 | $192,000 | July 1, 2022 | June 30, 2024 | PIRAS, IGNAZIO STEFANO | reporter.nih.gov |
| Genomic determinants of sleep traits as risk and protective factors for Alzheimer's disease | NIH | National Institute on Aging | 2022 | $192,000 | August 1, 2022 | January 31, 2025 | PIRAS, IGNAZIO STEFANO | reporter.nih.gov |
| Host DNA methylation as a mechanism of microbiome influence on internalizing behavior | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $103,415 | April 6, 2020 | March 31, 2022 | LEWIS, CANDACE RENEE | reporter.nih.gov |
| Mitochondrial Methionyl-tRNA Formyltransferase (MTFMT) Mouse Model to elucidate Mitochondrial Translation initiation Defect and Disease Mechanisms in Leigh Syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $9,026 | August 1, 2025 | December 31, 2025 | RANGASAMY, SAMPATHKUMAR | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 9 | $13,776,276 | 0 | $0 |
| 2024 | 10 | $15,711,097 | 0 | $0 |
| 2023 | 9 | $6,920,408 | 0 | $0 |
| 2022 | 10 | $5,262,341 | 0 | $0 |
| 2021 | 8 | $3,648,329 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) | PAR-25-095 | NIH | 93.866 | November 6, 2026 | $350,000 | Same assistance listing 93.866 as 4 awards here |
| Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed) | RFA-AG-27-010 | NIH | 93.866 | November 10, 2026 | Not listed | Same assistance listing 93.866 as 4 awards here |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 4 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 4 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 4 awards here |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) | PAR-25-096 | NIH | 93.866 | November 17, 2026 | $200,000 | Same assistance listing 93.866 as 4 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 4 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 4 awards here |
| HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) | RFA-AT-25-003 | NIH | 93.866 | November 23, 2026 | $375,000 | Same assistance listing 93.866 as 4 awards here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.866 | November 24, 2026 | Not listed | Same assistance listing 93.866 as 4 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.866 | December 3, 2026 | Not listed | Same assistance listing 93.866 as 4 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.866 | December 3, 2026 | Not listed | Same assistance listing 93.866 as 4 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.866 | December 4, 2026 | Not listed | Same assistance listing 93.866 as 4 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.866 | January 5, 2027 | Not listed | Same assistance listing 93.866 as 4 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.866 | January 5, 2027 | Not listed | Same assistance listing 93.866 as 4 awards here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.866 | January 7, 2027 | $375,000 | Same assistance listing 93.866 as 4 awards here |
| Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) | PAR-25-378 | NIH | 93.866 | January 7, 2027 | Not listed | Same assistance listing 93.866 as 4 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 4 awards here |
| HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) | RFA-NS-25-023 | NIH | 93.866 | January 15, 2027 | $350,000 | Same assistance listing 93.866 as 4 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 4 awards here |
Topics of its NIH awards
- Genetics
- Biotechnology
- Human Genome
- Rare Diseases
- Prevention
- Infectious Diseases
- Neurosciences
- Clinical Research
- Emerging Infectious Diseases
- Microbiome
- Brain Disorders
- Pediatric
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.